Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Susan Greenbloom"'
Autor:
Curtis Cooper, Stephen Shafran, Susan Greenbloom, Robert Enns, John Farley, Nir Hilzenrat, Kurt Williams, Magdy Elkashab, Nabil Abadir, Manuela Neuman
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 28, Iss 1, Pp 35-40 (2014)
BACKGROUND: Serum tumour necrosis factor-alpha (TNF-α) levels correlate negatively with hepatitis C virus (HCV) antiviral response.
Externí odkaz:
https://doaj.org/article/86d716f953a848e887b86bf777a0cec6
Autor:
Silvio Danese, Séverine Vermeire, Wen Zhou, Aileen L Pangan, Jesse Siffledeen, Susan Greenbloom, Xavier Hébuterne, Geert D'Haens, Hiroshi Nakase, Julian Panés, Peter D R Higgins, Pascal Juillerat, James O Lindsay, Edward V Loftus, William J Sandborn, Walter Reinisch, Min-Hu Chen, Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Michael A Weinreich, Remo Panaccione
Publikováno v:
The Lancet, 399(10341), 2113-2128. Elsevier Limited
BACKGROUND There is a great unmet need for advanced therapies that provide rapid, robust, and sustained disease control for patients with ulcerative colitis. We assessed the efficacy and safety of upadacitinib, an oral selective Janus kinase 1 inhibi
Autor:
Man‐Fung Yuen, Chi‐Yi Chen, Chun‐Jen Liu, Wen‐Juei Jeng, Magdy Elkhashab, Carla S. Coffin, Won Kim, Susan Greenbloom, Alnoor Ramji, Young S. Lim, Yoon J. Kim, Scott K. Fung, Dong J. Kim, Jeong‐Won Jang, Kwan Sik Lee, Radhakrishnan P. Iyer, Chelsea Macfarlane, Kathy Jackson, Stephen A. Locarnini, Henry L. Y. Chan, Nezam H. Afdhal
Publikováno v:
Liver international : official journal of the International Association for the Study of the LiverREFERENCES. 43(1)
Novel agents acting against hepatitis B virus (HBV) are needed to improve HBsAg seroclearance or termed as 'functional cure'. Inarigivir (retinoic acid-inducible gene I agonist) has immunomodulatory and direct antiviral actions against HBV. We aimed
Autor:
Edward V. Loftus, Jean-Frederic Colombel, Ana Paula Lacerda, Laurent Peyrin-Biroulet, Geert D’Haens, Remo Panaccione, Walter Reinisch, Edouard Louis, Minhu Chen, Hiroshi Nakase, Susan Greenbloom, George DuVall, Yuri Sánchez González, Mohamed-Eslam F. Mohamed, Susan Rhee, Tian Feng, Elena Dubcenco, Julián Panés
Publikováno v:
Gastroenterología y Hepatología. 46:S143
Autor:
Eric Lawitz, G. Mani Subramanian, Zeid Kayali, Edward Gane, Mazen Noureddin, Vincent Wai-Sun Wong, Jun Xu, Stephen A. Harrison, Sergio Rojter, Eliza Harting, Mary E. Rinella, Robert Herring, C. Stephen Djedjos, Robert P. Myers, James F. Trotter, Saumya Jayakumar, Chuhan Chung, Magdy Elkhashab, Keyur Patel, Susan Greenbloom, Andrew N. Billin, Mitchell L. Shiffman, Michael S. Middleton, Bradley Freilich
Publikováno v:
Hepatology. 72:58-71
Background and aims We evaluated the safety and efficacy of cilofexor (formerly GS-9674), a small-molecule nonsteroidal agonist of farnesoid X receptor, in patients with nonalcoholic steatohepatitis (NASH). Approach and results In this double-blind,
Autor:
Edward V. Loftus, Jean-Frederic Colombel, Ana Paula Lacerda, Laurent Peyrin-Biroulet, Geert D’Haens, Remo Panaccione, Walter Reinisch, Edouard Louis, Minhu Chen, Hiroshi Nakase, Susan Greenbloom, George DuVall, Yuri Sanchez-Gonzalez, Mohamed-Eslam Mohamed, Susan Rhee, Tian Feng, Elena Dubcenco, Julian Panés
Publikováno v:
American Journal of Gastroenterology. 117:e518-e518
Autor:
Jean-Frederic Colombel, Julian Panes, Ana P. Lacerda, Laurent Peyrin-Biroulet, Geert R. D'Haens, Remo Panaccione, Walter Reinisch, Edouard Louis, Minhu Chen, Hiroshi Nakase, Susan Greenbloom, George DuVall, Yuri Sanchez Gonzalez, Mohamed-Eslam F. Mohamed, Susan Rhee, Qian Zhou, Edward V. Loftus
Publikováno v:
Gastroenterology. 162:S-1394
Autor:
Michael Weinreich, Wen Zhou, Jianzhong Liu, Bidan Huang, Aileen L. Pangan, Silvio Danese, Geert R. D'Haens, Edward V. Loftus, Remo Panaccione, Pascal Juillerat, William J. Sandborn, Susan Greenbloom, Yuri Sanchez-Gonzalez, James O. Lindsay, Julián Panés, Walter Reinisch, Wangang Xian, Severine Vermeire
Publikováno v:
American Journal of Gastroenterology. 116:S357-S357
Introduction: U-ACCOMPLISH is one of two phase 3 induction trials evaluating safety and efficacy of upadacitinib-45 mg once daily (UPA) in adults with ulcerative colitis (UC). Methods: U-ACCOMPLISH, a multicentre, randomized, double-blind, placebo-co
Autor:
Ewa Janczewska, Adrian Streinu-Cercel, Brian Conway, István Tornai, Richard Skoien, David R. Shaw, Alejandro Soza, Mudra Kapoor, Wayne Ghesquiere, Xuan Liu, Thomas Podsadecki, Florin Alexandru Caruntu, Y. Liu, Gregory J. Dore, Danielle Sullivan, Francisco Fuster, Yan Luo, Manuela Curescu, Adriana Motoc, Olav Dalgard, Campbell Andrew L, Victoria Aramă, Brygida Knysz, Włodzimierz Mazur, Joe Sasadeusz, Susan Greenbloom
Publikováno v:
Journal of Hepatology. 64:19-28
Background & AimsTelaprevir plus pegylated interferon/ribavirin (TPV+PegIFN/RBV) remains a therapeutic option for chronic hepatitis C virus (HCV) genotype (GT) 1 infection in many regions. We conducted two open-label, phase IIIb trials comparing safe
Autor:
Ana P. Lacerda, Susan Greenbloom, Laurent Peyrin-Biroulet, Julián Panés, William J. Sandborn, Wen Zhou, Edouard Louis, Jianzhong Liu, Qian Zhou
Publikováno v:
Gastroenterology. 158:S-1187